Recognizes May 2026 as Guillain-Barré Syndrome Awareness Month in Pennsylvania.

Guillain-Barré syndrome (GBS) is a rare autoimmune condition that affects the peripheral nerves, typically requiring hospitalization due to the risk of muscle paralysis. The resolution highlights the importance of raising awareness about GBS, which affects 3,000 to 6,000 people annually in the United States. It also acknowledges ongoing research efforts by the National Institutes of Health and the World Health Organization, as well as advocacy by organizations like GBS-CIDP Foundation International.

Recognizes May 2026 as Guillain-Barré Syndrome Awareness Month in Pennsylvania.

Guillain-Barré syndrome (GBS) is a rare autoimmune condition that affects the peripheral nerves, typically requiring hospitalization due to the risk of muscle paralysis. The resolution highlights the importance of raising awareness about GBS, which affects 3,000 to 6,000 people annually in the United States. It also acknowledges ongoing research efforts by the National Institutes of Health and the World Health Organization, as well as advocacy by organizations like GBS-CIDP Foundation International.